Abdominal aortic dissection during sorafenib therapy for hepatocellular carcinoma.

Xu, Lin; Wang, Boqing; Ding, Wei

Xu, Lin; Wang, Boqing; Ding, Wei.

Affiliation

Xu L; Department of Hepatopancreatobiliary Surgery, The Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi 830000, China.
Wang B; Department of Hepatopancreatobiliary Surgery, The Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi 830000, China.
Ding W; Department of Hepatopancreatobiliary Surgery, The Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi 830000, China. Electronic address: xlawxh1015@163.com.

Clin Res Hepatol Gastroenterol ; 41(2): e24-e25, 2017 Mar.

Article in En | MEDLINE | ID: mdl-28163072

Subject(s)

Antineoplastic Agents/adverse effects; Aortic Aneurysm, Abdominal; Aortic Dissection; Carcinoma, Hepatocellular/drug therapy; Liver Neoplasms/drug therapy; Niacinamide/analogs & derivatives; Phenylurea Compounds/adverse effects; Stents; Aortic Dissection/chemically induced; Aortic Dissection/surgery; Antineoplastic Agents/administration & dosage; Aortic Aneurysm, Abdominal/chemically induced; Aortic Aneurysm, Abdominal/surgery; Endovascular Procedures/methods; Humans; Male; Middle Aged; Niacinamide/administration & dosage; Niacinamide/adverse effects; Phenylurea Compounds/administration & dosage; Sorafenib; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phenylurea Compounds / Stents / Aortic Aneurysm, Abdominal / Niacinamide / Carcinoma, Hepatocellular / Aortic Dissection / Liver Neoplasms / Antineoplastic Agents Limits: Humans / Male / Middle aged Language: En Journal: Clin Res Hepatol Gastroenterol Year: 2017 Document type: Article Affiliation country: China Country of publication: France

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google